GlassScriptPhysician profile
Xuan Cao
NPI 1780856740
$4,052.34
in general payments reported to CMS, 2019-2025
21 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.08 · 2020: $90.45 · 2021: $554 · 2022: $596 · 2023: $2,049 · 2024: $543 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,724.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,796.32 | 2023 | M22 |
| Abbvie INC. | $422.04 | 2019-2022 | |
| Emd Serono, INC. | $278.61 | 2021-2024 | Mavenclad, Mavenclad |
| Merz North America, INC. | $184.78 | 2023 | |
| Astellas Pharma US INC | $169.38 | 2023-2024 | Veozah |
| Abbott Laboratories | $142.02 | 2022 | |
| Neurocrine Biosciences, INC. | $131.68 | 2024 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $130.68 | 2022 | |
| Calliditas Therapeutics US INC. | $125.00 | 2024 | |
| Lundbeck LLC | $119.56 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $110.58 | 2021 | |
| Amneal Pharmaceuticals LLC | $102.45 | 2025 | Crexont |
| Daiichi Sankyo INC. | $79.34 | 2019-2021 | |
| Lupin INC. | $61.69 | 2019-2020 | |
| Agile Therapeutics, INC. | $52.61 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $36.55 | 2021-2025 | Nexplanon |
| Ethicon US, LLC | $31.57 | 2020 | |
| Hologic Sales and Service, LLC | $30.51 | 2021 | |
| Shield Therapeutics INC | $18.13 | 2024 | |
| Myovant Sciences INC. | $14.79 | 2021 | |
| Scynexis, INC. | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xuan Cao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.